Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot study
Authors:
Open Access
- 29 May 2023
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (8) , e30423
Abstract
Background: Individuals with sickle cell anemia (SCA) exhibit decreased exercise capacity. Anemia limits oxygen‐carrying capacity and affects cardiopulmonary fitness. The drug voxelotor raises hemoglobin in SCA. We hypothesized that voxelotor improves exercise capacity in youths with SCA.Methods: In a single‐center, open‐label, single‐arm, longitudinal interventional pilot study (NCT04581356), SCA patients aged 12 and older, stably maintained on hydroxyurea, were treated with 1500 mg voxelotor daily, and performed cardiopulmonary exercise testing before (CPET#1) and after voxelotor (CPET#2). A modified Bruce Protocol was performed on a motorized treadmill, and breath‐by‐breath gas exchange data were collected. Peak oxygen consumption (peak VO2), anaerobic threshold, O2 pulse, VE/VCO2 slope, and time exercised were compared for each participant. The primary endpoint was change in peak VO2. Hematologic parameters were measured before each CPET. Patient Global Impression of Change (PGIC) and Clinician Global Impression of Change (CGIC) surveys were collected.Results: Ten hemoglobin SS patients aged 12–24 completed the study. All demonstrated expected hemoglobin rise, with average +1.6 g/dL (p = .003) and P50 left shift of average −11 mmHg (p < .0001) with decreased oxygen off‐loading at low pO2. The change in % predicted peak VO2 from CPET#1 to CPET#2 ranged from −12.8% to +11.3%, with significant improvement of more than 5% in one subject, more than 5% decrease in five subjects, and insignificant change of less than 5% in four subjects. All 10 CGIC and seven of 10 PGIC responses were positive.Conclusion: In a plot study of 10 youths with SCA, voxelotor treatment did not improve peak VO2 in 9 out of 10 patients.Keywords
This publication has 25 references indexed in Scilit:
- Pediatric Exercise Testing: Value and Implications of Peak Oxygen UptakeChildren, 2017
- Cardiomyopathy With Restrictive Physiology in Sickle Cell DiseaseJACC: Cardiovascular Imaging, 2016
- Reduced fitness and abnormal cardiopulmonary responses to maximal exercise testing in children and young adults with sickle cell anemiaPhysiological Reports, 2015
- Longitudinal differences in aerobic capacity between children with sickle cell anemia and matched controlsPediatric Blood & Cancer, 2014
- Exercise tolerance, lung function abnormalities, anemia, and cardiothoracic ratio in sickle cell patientsAmerican Journal of Hematology, 2014
- Cardiopulmonary exercise testing before and after blood transfusion: a prospective clinical studyBritish Journal of Anaesthesia, 2014
- Aerobic Fitness Percentiles for U.S. AdolescentsAmerican Journal of Preventive Medicine, 2011
- Cardiopulmonary Stress Testing in Children With Sickle Cell Disease Who are on Long-term ErythrocytapheresisJournal of Pediatric Hematology/Oncology, 2008
- Understanding the Basics of Cardiopulmonary Exercise TestingMayo Clinic Proceedings, 2006
- Effects of Hydroxyurea Administration on the Body Weight, Body Composition and Exercise Performance of Patients with Sickle-Cell AnaemiaClinical Science, 1997